BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 10378089)

  • 1. Children with moderately elevated lead levels: is chelation with DMSA helpful?
    O'Connor ME; Rich D
    Clin Pediatr (Phila); 1999 Jun; 38(6):325-31. PubMed ID: 10378089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term efficacy of oral dimercaptosuccinic acid in children with low to moderate lead intoxication.
    Besunder JB; Anderson RL; Super DM
    Pediatrics; 1995 Oct; 96(4 Pt 1):683-7. PubMed ID: 7567330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of oral meso-2,3-dimercaptosuccinic acid therapy for low-level childhood plumbism.
    Liebelt EL; Shannon M; Graef JW
    J Pediatr; 1994 Feb; 124(2):313-7. PubMed ID: 8301445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled study of meso-2,3-dimercaptosuccinic acid for the management of childhood lead intoxication.
    Graziano JH; Lolacono NJ; Moulton T; Mitchell ME; Slavkovich V; Zarate C
    J Pediatr; 1992 Jan; 120(1):133-9. PubMed ID: 1309865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of dimercaptosuccinic acid and calcium disodium ethylenediaminetetraacetic acid versus dimercaptopropanol and ethylenediaminetetraacetic acid in children with lead poisoning.
    Besunder JB; Super DM; Anderson RL
    J Pediatr; 1997 Jun; 130(6):966-71. PubMed ID: 9202621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of calcium disodium versenate (CaNa2EDTA) chelation in moderate childhood lead poisoning.
    Markowitz ME; Bijur PE; Ruff H; Rosen JF
    Pediatrics; 1993 Aug; 92(2):265-71. PubMed ID: 8337028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of chelation therapy on the neuropsychological and behavioral development of lead-exposed children after school entry.
    Dietrich KN; Ware JH; Salganik M; Radcliffe J; Rogan WJ; Rhoads GG; Fay ME; Davoli CT; Denckla MB; Bornschein RL; Schwarz D; Dockery DW; Adubato S; Jones RL;
    Pediatrics; 2004 Jul; 114(1):19-26. PubMed ID: 15231903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The management of environmental lead exposure in the pediatric population: lessons from Clitty Creek, Thailand.
    Tantanasrikul S; Chaivisuth B; Siriratanapreuk S; Padungtod C; Pleubreukan R; Boonnark T; Worahan S; Bhumiratanarak P; Chomchai C
    J Med Assoc Thai; 2002 Aug; 85 Suppl 2():S762-8. PubMed ID: 12403258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of children with slightly elevated blood lead levels.
    Kimbrough RD; LeVois M; Webb DR
    Pediatrics; 1994 Feb; 93(2):188-91. PubMed ID: 8121729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lead-contaminated soil abatement and urban children's blood lead levels.
    Weitzman M; Aschengrau A; Bellinger D; Jones R; Hamlin JS; Beiser A
    JAMA; 1993 Apr; 269(13):1647-54. PubMed ID: 8455298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Need for the lead mobilization test in children with lead poisoning.
    Markowitz ME; Rosen JF
    J Pediatr; 1991 Aug; 119(2):305-10. PubMed ID: 1907320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is there lead in the suburbs? Risk assessment in Chicago suburban pediatric practices. Pediatric Practice Research Group.
    Binns HJ; LeBailly SA; Poncher J; Kinsella TR; Saunders SE
    Pediatrics; 1994 Feb; 93(2):164-71. PubMed ID: 8121725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lead poisoning in children.
    Berlin CM
    Curr Opin Pediatr; 1997 Apr; 9(2):173-7. PubMed ID: 9204246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Description of 3,180 courses of chelation with dimercaptosuccinic acid in children ≤ 5 y with severe lead poisoning in Zamfara, Northern Nigeria: a retrospective analysis of programme data.
    Thurtle N; Greig J; Cooney L; Amitai Y; Ariti C; Brown MJ; Kosnett MJ; Moussally K; Sani-Gwarzo N; Akpan H; Shanks L; Dargan PI
    PLoS Med; 2014 Oct; 11(10):e1001739. PubMed ID: 25291378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dimercaptosuccinic acid (succimer; DMSA) in inorganic lead poisoning.
    Bradberry S; Vale A
    Clin Toxicol (Phila); 2009 Aug; 47(7):617-31. PubMed ID: 19663612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Succimer (meso-2,3-dimercaptosuccinic acid (DMSA)) treatment of Andean children with environmental lead exposure.
    Counter SA; Ortega F; Shannon MW; Buchanan LH
    Int J Occup Environ Health; 2003; 9(2):164-8. PubMed ID: 12848245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lead poisoning risk determination in an urban population through the use of a standardized questionnaire.
    Schaffer SJ; Szilagyi PG; Weitzman M
    Pediatrics; 1994 Feb; 93(2):159-63. PubMed ID: 8121724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of childhood lead poisoning: a survey.
    Glotzer DE; Bauchner H
    Pediatrics; 1992 Apr; 89(4 Pt 1):614-8. PubMed ID: 1313555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meso-2,3-dimercaptosuccinic acid in the treatment of occupationally exposed lead workers.
    Restek-Samarzija N; Blanusa M; Pizent A; Samarzija M; Turk R; Corović N; Jurasović J
    Arh Hig Rada Toksikol; 1998 Jun; 49(2):137-45. PubMed ID: 9919719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of oral dimercaptosuccinic acid (succimer) in adult patients with inorganic lead poisoning.
    Bradberry S; Sheehan T; Vale A
    QJM; 2009 Oct; 102(10):721-32. PubMed ID: 19700440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.